Headline RoundupApril 13th, 2021

Federal Health Agencies Call to Pause Johnson & Johnson Vaccine

Summary from the AllSides News Team

The FDA and CDC have requested a pause in the use of Johnson & Johnson’s single-dose COVID-19 vaccine after six U.S. recipients developed a rare disorder involving blood clots within nearly two weeks of vaccination, officials said on Tuesday. The officials said the clots appear to be rare, but people who develop severe headache, abdominal pain, leg pain or shortness of breath within three weeks after vaccination should contact their doctor. More than 6.8 million doses of the Johnson & Johnson vaccine have been administered in the U.S., the vast majority with no or mild side effects.

Featured Coverage of this Story

More headline roundups

More News about Coronavirus from the Left, Center and Right

From the Left

From the Center

From the Right